New Macrocyclic Diterpenes From Euphorbia Connata Boiss. With Cytotoxic Activities on Human Breast Cancer Cell Lines Publisher Pubmed

Summary: Scientists report plant compounds from Euphorbia connata may slow breast cancer cell growth, suggesting potential new treatments. #CancerResearch #HerbalMedicine

Shadi S¹ ; Saeidi H¹ ; Ghanadian M^{2, 3} ; Rahimnejad MR¹ ; Aghaei M³ ; Ayatollahi SM⁴ ; Iqbal Choudhary M^{5, 6}
Source: Natural Product Research Published:2016

Abstract

Acetone:chloroform (1:2) extract of the aerial parts of Euphorbia connata Boiss. (Euphorbiaceae) was investigated for its diterpenoids. This led to the isolation of one known and two new diterpenes, belonging to the pentahydroxy-13(17)-epoxy-8,10(18)-myrsinadiene and tetrahydroxy-5,6-epoxy-14-oxo-jatropha-11(E)-ene classes. The structures were elucidated based on 13C and 1H NMR as well as 2D NMR, IR and MS spectra and the cytotoxicity for compounds 1-3 were evaluated by using MTT assay against two human breast cancer cell lines. Myrsinane-type compounds - 3,7,14,15-tetraacetyl-5-propanoyl-13(17)-epoxy-8,10(18)-myrsinadiene (1) and 3,7,10,14,15-pentaacetyl-5-butanoyl-13,17-epoxy-8-myrsinene (2) - exhibited moderate inhibitory effects, with IC50 values of 24.53 ± 3.39 and 26.67 ± 1.41 μM against the MDA-MB cell line, and 37.73 ± 3.41 and 34.57 ± 2.12 μM against the MCF-7 cell line, respectively. Jatrophane-type diterpene - 5,6-epoxy-8,9,15-triacetyl-3-benzoyl-14-oxo-jatropha-11(E)-ene (3) - showed weak cytotoxicity, with IC50 values of 55.67 ± 7.09 μM against MDA-MB, and moderate cytotoxicity with IC50 values of 24.33 ± 3.21 μM against MCF-7 cell line. © 2014 Taylor & Francis.